
Expert Insights: From animal to iPSC-derived models, a new era in preclinical evaluation

Case Study: Development of a human iPSC-derived ALS model
-1.png)
The status of drug discovery and development for Parkinson's disease

Uncovering ALS pathology and potential drug targets with in vitro iPSC models
-1.png)
The status of drug discovery and development for Alzheimer's disease

Case Study: Modeling Friedreich’s ataxia using patient-derived iPSCs